Frank
Analyst
Lyric Partners
Equibles does not estimate personal net worth.
About Frank
Frank is recorded as Analyst at Lyric Partners. Frank has spoken on 1 earnings call across 1 company, most recently for Lexicon Pharmaceuticals, Inc. on November 5, 2026. The companies whose calls Frank spoke on are classified in the Healthcare sector.
Frank on recent calls
“My question relates to the Sonata HCM trial with, you know, 440 non-obstructive patients and 102 obstructive patients. And I'm curious, what level of consistency across the two groups would you need to support a broad HCM label?”
Affiliation history
-
Lyric Partners
Analyst
Transcript header (unverified)
Current